Firefly Neuroscience Announces Merger Completion and Nasdaq Listing

TORONTO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- In a landmark announcement, Firefly Neuroscience, Inc. (henceforth referred to as 'Firefly' or the 'Company'), a pioneering Artificial Intelligence (AI) technology firm focusing on the development of cutting-edge neuroscientific solutions for mental illness and neurological disorders, has informed its esteemed stockholders of the successful completion of its merger and subsequent listing on Nasdaq.

Milestone Merger and Nasdaq Listing

Representing a significant stride in the Company's expansion and market presence, both WAVD and AIFF are expected to benefit from increased visibility and investment potential owing to this recent development. The merger is anticipated to leverage Firefly's innovative AI-driven approaches with an aim to enhance the quality of interventions and outcomes for patients grappling with various mental and neurological health challenges.

Future Prospects for Firefly Neuroscience

Post-merger, Firefly is set to embark on a new phase of growth, underpinned by its strategic initiatives and research capabilities. With an AI-centric approach to neuroscience, the Company is well-positioned to contribute to advancements in the field and offer substantial value to its stockholders and patients alike. As it stands on the cusp of potentially transformative breakthroughs, Firefly's narrative is one of optimism, driven by a commitment to innovation and patient care in the mental health sector.

Merger, Nasdaq, Innovation